Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
Award Notice Posted
- Solicitation number
- 75N95024R00094
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Curia Global Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95026D00006 Federal IDV award
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Place of performance
- Albany, New York 12203, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases awarded a competitive multiple-award IDIQ contract to Curia Global Inc. for chemistry, manufacturing, and controls and related services for development of drug substances, with a contract value of $49.7 million and an ordering period from August 1, 2026 through May 14, 2031.
Task orders issued under the contract will most likely be cost-reimbursement, term/completion type. Fixed-price task orders are anticipated to be infeasible due to the absence of precise specifications and difficulties in cost estimation; the dynamic, science-responsive, and results-driven nature of the work creates uncertainties that would place undue risk on the Government in a fixed-price environment. Fixed-price task orders may be issued where appropriate and feasible. The contractor is eligible for task orders under Technical Areas 1 and 3. No set-aside was used for this award.
Notice text
A competitive multiple award, Indefinite Delivery/Indefinite Quantity (ID/IQ) type contract was awarded, with a ordering period (August 1, 2026 through May 14, 2031). It is anticipated that Task Orders issued against these contracts will most likely be cost-reimbursement, term/completion type Task Orders. Upon analysis of the type of work and all associated costs involved, fixed-price type task orders are usually not feasible due to the absence of precise specifications and difficulties in estimating costs with accuracy. Based upon the uncertainties involved, the Government would assume undue risk in attempting to fit relatively dynamic (science responsive and result-drive) requirement into a fixed-price environment. In these instances, fixed-price task orders would be disadvantageous to the Government, since they do not provide the Government with the flexibility that is needed to reasonably and responsively shift with the evolving needs of this requirement. However, fixed price Task Order may be issued, where appropriate and feasible.
The Contractor is eligible for Task Orders under Technical Areas 1 and 3.
The award notice is in relation to Solicitation # 75N95024R00094.
Awarded contract 75N95026D00006 to CURIA GLOBAL INC for 49713679.00 on 2026-08-01.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances | Award Notice | |
| Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances | Award Notice | |
| Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances | Award Notice | |
| This notice | Award Notice | |
| Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances | Solicitation |
5 of 7 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity